Dynamic Technology Lab’s Aclaris Therapeutics ACRS Stock Holding History

Dynamic Technology Lab’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,135	Closed	-$97K	–	995
2023 Q3	$97K	Buy	+14,135	New	+$121K	0.01%	866
2022 Q1	–	Sell	-13,873	Closed	-$201K	–	1057
2021 Q4	$201K	Buy	+13,873	New	+$210K	0.02%	962
2021 Q3	–	Sell	-24,061	Closed	-$422K	–	1018
2021 Q2	$422K	Buy	+24,061	New	+$547K	0.04%	654
2018 Q2	–	Sell	-11,325	Closed	-$198K	–	944
2018 Q1	$198K	Buy	+11,325	New	+$240K	0.03%	901
2017 Q4	–	Sell	-12,729	Closed	-$328K	–	970
2017 Q3	$328K	Buy	+12,729	New	+$341K	0.05%	679
2017 Q1	–	Sell	-7,670	Closed	-$209K	–	936
2016 Q4	$209K	Buy	+7,670	New	+$196K	0.06%	703

Other funds holding ACRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Dynamic Technology Lab's ACRS Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Aclaris Therapeutics (ACRS) in Q4 2023, closing a stake of 14,135 shares — an estimated $97K sold.

Dynamic Technology Lab first reported a position in ACRS in Q4 2016 and held it in 6 quarters. The position peaked at $422K in Q2 2021. 107 funds tracked by Wall St. Rank hold ACRS as of Q4 2023.

Dynamic Technology Lab reported no remaining Aclaris Therapeutics position as of Q4 2023 after selling out during the quarter.
Dynamic Technology Lab sold 14,135 Aclaris Therapeutics shares in Q4 2023, an estimated $97K.
Dynamic Technology Lab first reported a position in Aclaris Therapeutics in Q4 2016 and held it in 6 quarters.
Dynamic Technology Lab's Aclaris Therapeutics position peaked at $422K in Q2 2021.
107 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.